1.Risk factors for progressive cardiogenic stroke
Lanlan CHEN ; Daihua TAO ; Jun XU ; Yao XU ; Hailong YU ; Tingting QIAO ; Li JIANG
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2018;20(1):50-54
Objective To study the risk factors for progressive cardiogenic stroke (CS).Methods Seventy-one acute ischemic stroke patients admitted to our hospital from 2008-08-01 to 2014-12-31 were divided into progressive CS group (n=14) and non-progressive CS group (n=57).The NIHSS was used to assess the neurologic deficit when the patients were admitted and 30 days after the stroke onset.Their clinical data were retrospectively analyzed.The risk factors for progressive CS were analyzed by univariate logistic regression analysis and multivariate logistic regression analysis respectively,their critical thresholds were analyzed according to the ROC curve.Results The NIHSS improvent of the progressive CS group was significantly less than that of the non-progressive CS group (P<0.01).The age was significantly older,the incidence of right-side infarction and the serum level of D-dimer were significantly higher while the serum level of glutamic pyruvic transaminase was significantly lower in progressive CS group than in non-progressive CS group (77.29±8.87 years vs 71.44±9.51 years,P=0.041;71.4% vs 33.3%,P=0.009;2.82 mg/L vs 0.91 mg/L,P=0.048;13.79±4.44 U/L vs 21.98±17.34 U/L,P=0.002).Lo gistic regression analysis showed a significant difference in age,right-side infarction and serum D-dimer level between the two groups (P=0.030,P=0.007,P=0.025).The area under the ROC curve revealed that age > 70.75 years and serum D-dimer level >1.23 mg/L were the risk factors for progressive CS.Conclusion Age,right-side infarction and serum D-dimer level are the risk factors for progressive CS and can thus be used as predictors of progressive CS.
2.New progress in the first-line treatment of advanced hepatocellular carcinoma
Chuanhui ZHANG ; Dongyue YAO ; Siqi LIU ; Lanlan YANG ; Zhenjing JIN
Chinese Journal of Hepatology 2024;32(2):173-179
Hepatocellular carcinoma is a kind of cancer with a strong invasion, a high incidence rate and mortality, and a poor prognosis. At the time of diagnosis, most patients are already in the advanced stages of a tumor and have lost the chance for radical surgical treatment. Advanced hepatocellular carcinoma treatment has a gradual transition from systemic chemotherapy to targeted therapy, immunotherapy, and combination therapy, especially immune checkpoint inhibitor-based immunotherapy combination therapy, such as combination with bevacizumab monoclonal antibodies and other drugs, or combination with TACE, HAIC, radiotherapy, ablation, and other treatment methods. Combination therapy has significant synergistic effects and thus has already become a future treatment trend for hepatocellular carcinoma. An immunotherapy-based combination therapy plan will run through the whole process of systemic therapy, which is expected to bring better survival benefits to patients with hepatocellular carcinoma. This article reviews the latest research progress in aspects of the first-line treatment of advanced hepatocellular carcinoma.
3.The Relationship between the Gene Polymorphism of Tumor Necrosis Factor-αPromoter Region in Hyperuricemia Patients and its Metabolic Phenotype
Lanlan YAO ; Xinyan CHEN ; Feng XU ; Jie PAN ; Yangang WANG
China Modern Doctor 2008;46(1):1-5
Objective To investigate the correlation between the-308 site,-238 site gene polymorphism of TNF-αa promoter region in hypemricemh and its metabolic phenotype.Methods HUA patients 188,normal people(NHU)51,the-308G/A site single nu-cleofide polymorphism of TNF-a gene promoter region was decided by Polymerase chain reaction-restriction fragment length polymor-phism(PCR-RFLP)method.The level of serum uric acid is detected by uricase.blood glucose by glucose oxidase.Selective inhibition assay for total cholesterol,triglyceride and high-density lipoprotein cholesterol.All these tests were complted within three hours afterextraction.Keep blood samples at-20℃ to detect the concentration of insulin using immunoradiometrie assay.HUA patients 35.NHU 39,the -238G/A site single nucleofide polymorphism of TNF-a gene promoter region was decided by the same method.Results By smdying two single nucleotide polymorphism,the GA+AA frequency of-308 site(23.94%)in HUA was significantly higher than NHU(11.76%)(P=0.0001);the genotype frequencies of GA and GG in-238 site had no significant difference between the two groups(P=0.08).Meanwhile,comparing GA+AA genotype and CG group of-308 site,waist-hip ratio,systolic and diastolic blood pressure,uric acid,triglycerides differences were statistically significant(P=0.05-0.01);the difference in-238 site between the two genotypes waft no significance.Conclusion The results of this study show-308A carriers of TNF-α promoter region in HUA individual is correlated with hyperuficemia and its metabolic phenotype.
4.Fluid management strategies for patients with severe blast injury
Minfei YANG ; Mengyun XU ; Yu KE ; Xiao LU ; Lanlan ZHANG ; Xiaoyue YAO
Chinese Journal of Practical Nursing 2023;39(14):1105-1109
Objective:To summarize the precision fluid management of patients with severe blast injury in the emergency intensive care unit, so as to help patients smoothly pass through the dangerous period and recover smoothly.Methods:Based on the experience of fluid management in 6 patients admitted to the Second Affiliated Hospital Zhejiang University School of Medicine in the tanker truck explosion on 14 June, 2020. The main measures included: fluid volume management and dynamic adjustment; assessment of intake, output and urine volume, and dynamic adjustment of infusion volume and speed; monitoring of pulmonary oxygenation and timely adjustment of fluid resuscitation strategies; monitoring indexes and providing nursing care strategies for fluid management.Results:Finally, among 6 patients with severe blast injury, 5 patients were discharged from the hospital with follow-up treatment after they suffered from the shock and infection phases and refined fluid management, 1 patient died due to severe injury and ineffective rescue.Conclusions:Adopting individualized, phased, and refined liquid management strategy has clinical significance for patients with severe blast injury to smoothly pass the risk period.
5.The establishment and implementation of physique nursing clinic of Traditional Chinese Medicine
Lanlan CHEN ; Yiping WANG ; Xingfeng LU ; Li LIU ; Fei YAO ; Feng CHEN
Chinese Journal of Nursing 2018;53(5):584-587
In order to understand the patients' physique accurately,and formulate individualized conditioning scheme for patients with biased physique,our hospital established a new clinic called physique nursing clinic of Traditional Chinese Medicine (TCM) in August 2017,formed a series of corresponding rules and management regulations,and made clear the focus of the clinic and the work content of outpatient nurses.After implementation,the physique nursing clinic of TCM has achieved various goals:a total of 526 cases of TCM physique identification were carried out,324 patients with biased physique were given health guidance,and 148 cases of referral treatment.Hospital organized clinic members to go out to study for 10 times,and the voluntary community clinic were developed for 4 times.The physique nursing clinic of TCM has been appreciated by outpatients,doctors and nurses,who believed it could meet patients' individualized health needs and promote the development of TCM nursing.
6.A comparative study with real-world data of different surgery for lung malignancies in the context of DRG payment
Yuanlin WU ; Yao LIU ; Lanlan GAN ; Guiyuan XIANG ; Chen LI ; Shigeng CHEN ; Qiuwan XIAN
Chongqing Medicine 2024;53(11):1645-1649
Objective To compare the safety,effectiveness and affordability of robotic-assisted thoracic surgery and video-assisted thoracic surgery in the treatment of malignant pulmonary tumors,and provide ref-erences for the management of selection of different surgical strategies for malignant pulmonary tumors in hospitals and medical insurance departments.Methods The medical records homepages and information sys-tem data of patients with malignant pulmonary tumors who underwent major thoracic surgery in this hospital and discharged from January 1 to December 31,2022 were obtained.The patients were divided into the robotic-assistedthoracic surgery group and video-assisted thoracic surgery group according to the surgical methodolo-gies.After performing propensity score matching (PSM),no statistically significant difference was observed in baseline data between the two groups (117 cases in each group).Then the indicators of safety,effectiveness and affordability were compared between the two groups.Results Concerning the safety,the postoperative in-cision infection rate in the robotic-assisted thoracic surgery group was significantly lower than that in the vide-o-assisted thoracic surgery group (P<0.05),and the amount of intraoperative blood loss and postoperative complication rate were not significantly different between the two groups (P>0.05).Regarding the effective-ness,the average surgical duration in the robotic-assisted thoracic surgery group was appreciably shorter than that in the video-assisted thoracic surgery group (P<0.05),no patient in the two groups was converted to open thoracotomy,and there was no statistically significant difference in the average length of hospital stay and postoperative hospital stay between the two groups (P>0.05).With regard to the affordability,the aver-age inpatient expenditure per case and average daily inpatient expenditure per case in the robotic-assisted tho-racic surgery group were significantly higher than those in the video-assisted thoracic surgery group (P<0.05),and there were disparities in the cost structure between the two procedures.The medical cost,adminis-tration cost and consumables cost in the robotic-assisted thoracic surgery group were significantly higher than those in the video-assisted thoracic surgery group (P<0.05).The cost of medical technology in the robotic-assisted thoracic surgery group was significantly lower than that in the video-assisted thoracic surgery group (P<0.05).Conclusion Physicians should comprehensively consider the clinical efficacy and cost burden of patients when selecting the robotic-assisted thoracic surgery or the video-assisted thoracic surgery,and the monitoring and evaluation of the utilization of clinical robotic-assisted thoracic surgery should be strength-ened.
7.Exploration and construction of the new generation of intelligent ICU unit based on 5G and artificial intelligence technology
Xiaoxia HUANG ; Yao LI ; Haotian CHEN ; Jiaying TANG ; Xu WANG ; Qiang LI ; Fangmin GE ; Dong CHEN ; Yonghua CHU ; Jianping YE ; Lanlan WU ; Shuaifeng LÜ ; Mao ZHANG
Chinese Journal of Emergency Medicine 2021;30(10):1269-1273
Objective:To explore the new generation of intelligent ICU Unit based on 5G and artificial intelligence technology.Methods:This study was conducted at the Second Affiliated Hospital, Zhejiang University School of Medicine from May 2019 to August 2020. Based on a multidisciplinary team including medical, nursing, hospital management, clinical medical engineering, 5G technology, information technology, artificial intelligence technology, logistics service, etc, was assembled to intelligently design and reconstruct an intelligent ICU Unit of Emergency ICU.Results:Based on 5G technology, a new intelligent ICU unit environment was constructed to realize remote and high-speed interaction of multi-dimensional information in ICU, including intelligent assistance of remote monitoring, remote ward rounds, remote consultation and family visits. An intelligent hospital infection prevention and control system was established including automatic identification and alarm of hand hygiene and personal protection.Conclusions:The new generation of intelligent ICU unit combined with 5G and artificial intelligence technology has changed the mode of medical service for critically ill patients and improved the service level, which is worthy of further exploration and application.
8.Analysis of the grouping effect and hospitalization cost of patients with malignant proliferative disease in a hospital under DRG payment
Guiyuan XIANG ; Yuanlin WU ; Lanlan GAN ; Shigeng CHEN ; Yao LIU
China Pharmacy 2023;34(13):1637-1641
OBJECTIVE To analyze the grouping effect and composition of hospitalization costs for cases of patients with malignant proliferative disease under the diagnosis-related group (DRG) payment system, as well as any changes, in order to provide a basis for medical institutions to improve DRG payment-related measures, control drug costs, and for relevant departments to make decisions. METHODS The data of patients with malignant proliferative disease cases were collected from a “Third Grade Class A” hospital in 2021 and 2022, and the variation coefficient (CV) was used to evaluate the grouping of DRG. The structural variation degree and the new grey correlation analysis were used to study the structural variation of hospitalization cost and the correlation degree between the hospitalization cost and the cost of other items. RESULTS The overall reduction in variance (RIV) for the DRG group of patients with malignant proliferative disease was 79.36%; the CV of other groups were all lower than one except that the RW21 group was 1.09. Compared with 2021, the hospitalization cost for patients with malignant proliferative disease in 2022 decreased by 17.80%, and the decreases in management fees and drug costs were 32.15% and 21.30%, respectively, while the per capita medical expenses increased by 17.26%. The new grey correlation degree of drug cost decreased, but that of medical expenses increased. CONCLUSIONS Under the DRG payment system, hospitalization costs for patients with malignant proliferative disease in the sample hospital decrease, but the grouping efficiency of RW21 and other disease groups needs improvement, and the cost structure needs optimization.
9.Recent progress in advanced glycation end-products of gestational diabetes mellitus
Shiyu LIU ; Jiaxin FU ; Yibo MENG ; Lanlan PENG ; Hui CHEN ; Xue XIAO ; Yuan YAO
Chinese Journal of Endocrine Surgery 2018;12(4):345-347,352
Advanced glycation end-products (AGEs) are stable and toxic by-products of non-enzymatic metabolic reaction of proteins,lipids and nucleotides.The elevated serum AGEs level in pregnant women is strongly associated with hyperglycemia,oxidative stress and insulin resistance and may be one of the cause for the onset and development of the gestational diabetes mellitus(GDM).This review mainly focuses on the pathogenesis of AGEs and GDM.